ArticleFrontiers in immunology2023

Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study.

Blanka Wolszczak-Biedrzycka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.